Hong Cui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hong Cui has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Bingxin Zhang
Department of Dermatology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin, China
2 shared publications - Lizhi Hu
Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, China
2 shared publications - Pan Guo
Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China; Tianjin Pediatric Research Institute, Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Children's Hospital, Tianjin University (Tianjin Children's Hospital), Tianjin, China
2 shared publications - Bingkun Wang
Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China
1 shared publication - Fengtong Li
Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China
1 shared publication - Jing Luo
Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin 300070, China
1 shared publication
Latest Publications
- 5 May 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 181, 116750
iNOS deficiency aggravates DNFB-induced atopic dermatitis in mice
- 5 May 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 181, 116750
iNOS deficiency aggravates DNFB-induced atopic dermatitis in mice
- 9 December 2025
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 106 (6) , e70220
Screening Potential Drugs From Nitric Oxide Donors for Treating Alopecia Based on Network Pharmacology and Experimental Validation
Nitric oxide (NO) was previously thought to have a beneficial role in hair growth, but it is unclear whether NO donors can encourage hair development. Therefore, this study aims to systematically investigate the physiological mechanisms underlying the therapeutic effects of NO donors in alopecia. We first screened the chemical targets of seven types of NO donors from DrugBank and SwissTargetPrediction, and further identified the differentially expressed genes (DEGs) of three types of alopecia from the GEO database. Integrated bioinformatic analysis was subsequently performed to comprehensively reveal potential pathways. A total of 339 chemical targets of NO donors were collected and 237, 266, and 1158 DEGs of androgenic alopecia (AGA), alopecia areata (AA) and central centrifugal cicatricial alopecia (CCCA) were identified in this study. We further extracted 20 CCCA‐related targets from the intersection of 339 targets and 1158 DEGs of CCCA for the following analysis. Through integrative analysis, we found that hesperidin (HP) may exert dual regulatory effects on apoptosis and senescence pathways in hair follicle cells through its specific interactions with BCL2, MAPK8, MMP13 and AURKB, effectively mitigating hair loss. Overall, our work elucidates the molecular mechanisms of NO donors‐mediated hair follicle protection, which could pave the way for future investigations into NO‐based interventions and their potential clinical applications.
- 9 December 2025
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 106 (6) , e70220
Screening Potential Drugs From Nitric Oxide Donors for Treating Alopecia Based on Network Pharmacology and Experimental Validation
Nitric oxide (NO) was previously thought to have a beneficial role in hair growth, but it is unclear whether NO donors can encourage hair development. Therefore, this study aims to systematically investigate the physiological mechanisms underlying the therapeutic effects of NO donors in alopecia. We first screened the chemical targets of seven types of NO donors from DrugBank and SwissTargetPrediction, and further identified the differentially expressed genes (DEGs) of three types of alopecia from the GEO database. Integrated bioinformatic analysis was subsequently performed to comprehensively reveal potential pathways. A total of 339 chemical targets of NO donors were collected and 237, 266, and 1158 DEGs of androgenic alopecia (AGA), alopecia areata (AA) and central centrifugal cicatricial alopecia (CCCA) were identified in this study. We further extracted 20 CCCA‐related targets from the intersection of 339 targets and 1158 DEGs of CCCA for the following analysis. Through integrative analysis, we found that hesperidin (HP) may exert dual regulatory effects on apoptosis and senescence pathways in hair follicle cells through its specific interactions with BCL2, MAPK8, MMP13 and AURKB, effectively mitigating hair loss. Overall, our work elucidates the molecular mechanisms of NO donors‐mediated hair follicle protection, which could pave the way for future investigations into NO‐based interventions and their potential clinical applications.